The Princess Margaret’s Dr. Ian Tannock and Dr. Natasha Leighl honoured with 2019 ASCO Awards

22/03/2019


The Princess Margaret’s Dr. Ian Tannock and Dr. Natasha Leighl have both been honoured with 2019 awards from the American Society of Clinical Oncology (ASCO). 

Dr. Tannock, Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre and the University of Toronto, was awarded the 2019 Allen S. Lichter Visionary Leader Award. With clinical expertise in genitourinary and breast cancer, Dr. Tannock’s work involves researching methods related to cancer clinical trials. He also chaired trials for men with metastatic prostate cancer that led to licensing of new drugs that are being used around the world.

Dr. Leighl, medical oncologist at The Princess Margaret and Professor in the Department of Medicine at the U of T, was awarded the 2019 Excellence in Teaching Award. Dr. Leighl leads the Cancer Centre’s Thoracic Medical Oncology Group and has mentored many oncology trainees that have gone on to have an impact in oncology worldwide. Her area of focus includes developing new treatments in lung cancer and outcomes research such as pharmacoeconomics. Dr. Leighl also holds the combined hospital/university OSI Pharmaceuticals Foundation Chair in Cancer New Drug Development and has led several international and cooperative group studies in lung cancer. 

For more on the awards and this year’s recipients visit ASCO.